Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1999; Volume 56,Issue 3

Articles

  • You have access
    Dietary Glycine and Renal Denervation Prevents Cyclosporin A-Induced Hydroxyl Radical Production in Rat Kidney
    Zhi Zhong, Henry D. Connor, Ming Yin, Nicholas Moss, Ronald P. Mason, Hartwig Bunzendahl, Donald T. Forman and Ronald G. Thurman
    Molecular Pharmacology September 1999, 56 (3) 455-463; DOI: https://doi.org/10.1124/mol.56.3.455
  • You have access
    A Novel Domain of the Inhibitory Glycine Receptor Determining Antagonist Efficacies: Further Evidence for Partial Agonism Resulting from Self-Inhibition
    Volker Schmieden, Jochen Kuhse and Heinrich Betz
    Molecular Pharmacology September 1999, 56 (3) 464-472; DOI: https://doi.org/10.1124/mol.56.3.464
  • You have access
    Developmental Action of Estrogen Receptor-α Feminizes the Growth Hormone-Stat5b Pathway and Expression of Cyp2a4 andCyp2d9 Genes in Mouse Liver
    Tatsuya Sueyoshi, Norihiko Yokomori, Kenneth S. Korach and Masahiko Negishi
    Molecular Pharmacology September 1999, 56 (3) 473-477; DOI: https://doi.org/10.1124/mol.56.3.473
  • You have access
    DNA Protein Cross-Links Produced by NSC 652287, a Novel Thiophene Derivative Active Against Human Renal Cancer Cells
    Wilberto Nieves-Neira, Maria I. Rivera, Glenda Kohlhagen, Miriam L. Hursey, Philippe Pourquier, Edward A. Sausville and Yves Pommier
    Molecular Pharmacology September 1999, 56 (3) 478-484; DOI: https://doi.org/10.1124/mol.56.3.478
  • You have access
    Spontaneous β2-Adrenergic Signaling Fails To Modulate L-Type Ca2+ Current in Mouse Ventricular Myocytes
    Ying-Ying Zhou, Heping Cheng, Long-Sheng Song, Dingji Wang, Edward G. Lakatta and Rui-Ping Xiao
    Molecular Pharmacology September 1999, 56 (3) 485-493; DOI: https://doi.org/10.1124/mol.56.3.485
  • You have access
    Mechanism-Based Chemopreventive Strategies Against Etoposide-Induced Acute Myeloid Leukemia: Free Radical/Antioxidant Approach
    Valerian E. Kagan, Jack C. Yalowich, Grigory G. Borisenko, Yulia Y. Tyurina, Vladimir A. Tyurin, Padmakumari Thampatty and James P. Fabisiak
    Molecular Pharmacology September 1999, 56 (3) 494-506; DOI: https://doi.org/10.1124/mol.56.3.494
  • You have access
    Suppression of Flavin-Containing Monooxygenase by Overproduced Nitric Oxide in Rat Liver
    Chang-Shin Park, Hyun-Moon Baek, Woon-Gye Chung, Kyung-Hoon Lee, Seung-Duk Ryu and Young-Nam Cha
    Molecular Pharmacology September 1999, 56 (3) 507-514; DOI: https://doi.org/10.1124/mol.56.3.507
  • You have access
    Ras Mutation, Irrespective of Cell Type and p53 Status, Determines a Cell’s Destiny to Undergo Apoptosis by Okadaic Acid, an Inhibitor of Protein Phosphatase 1 and 2A
    Deepika Rajesh, Kathleen Schell and A. K. Verma
    Molecular Pharmacology September 1999, 56 (3) 515-525; DOI: https://doi.org/10.1124/mol.56.3.515
  • You have access
    Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase 1A1 Promoters by Hepatocyte Nuclear Factor 1
    Pascal Bernard, Hervé Goudonnet, Yves Artur, Béatrice Desvergne and Walter Wahli
    Molecular Pharmacology September 1999, 56 (3) 526-536; DOI: https://doi.org/10.1124/mol.56.3.526
  • You have access
    Post-Translational Regulation of AP-1 Transcription Factor DNA-Binding Activity in the Rat Conceptus
    Terence R. S. Ozolinš and Barbara F. Hales
    Molecular Pharmacology September 1999, 56 (3) 537-544; DOI: https://doi.org/10.1124/mol.56.3.537
  • You have access
    Importance of the Extracellular Domain for Prostaglandin EP2 Receptor Function
    Brett A. Stillman, Matthew D. Breyer and Richard M. Breyer
    Molecular Pharmacology September 1999, 56 (3) 545-551; DOI: https://doi.org/10.1124/mol.56.3.545
  • You have access
    Pharmacological and Molecular Characterization of 5-Hydroxytryptamine7 Receptors in the Rat Adrenal Gland
    Vincent Contesse, Sebastien Lenglet, Luca Grumolato, Youssef Anouar, Isabelle Lihrmann, Herve Lefebvre, Catherine Delarue and Hubert Vaudry
    Molecular Pharmacology September 1999, 56 (3) 552-561; DOI: https://doi.org/10.1124/mol.56.3.552
  • You have access
    Phosphorylation of Deoxycytidine Analog Monophosphates by UMP-CMP Kinase: Molecular Characterization of the Human Enzyme
    An R. Van Rompay, Magnus Johansson and Anna Karlsson
    Molecular Pharmacology September 1999, 56 (3) 562-569; DOI: https://doi.org/10.1124/mol.56.3.562
  • You have access
    The Antiviral Nucleotide Analogs Cidofovir and Adefovir Are Novel Substrates for Human and Rat Renal Organic Anion Transporter 1
    Tomas Cihlar, Deborah C. Lin, John B. Pritchard, Michael D. Fuller, Dirk B. Mendel and Douglas H. Sweet
    Molecular Pharmacology September 1999, 56 (3) 570-580; DOI: https://doi.org/10.1124/mol.56.3.570
  • You have access
    The Cloned Rat Vanilloid Receptor VR1 Mediates Both R-Type Binding and C-Type Calcium Response in Dorsal Root Ganglion Neurons
    Arpad Szallasi, Peter M. Blumberg, Lauren L. Annicelli, James E. Krause and Daniel N. Cortright
    Molecular Pharmacology September 1999, 56 (3) 581-587; DOI: https://doi.org/10.1124/mol.56.3.581
  • You have access
    Oxidative Inactivation of Cytochrome P-450 1A (CYP1A) Stimulated by 3,3′,4,4′-Tetrachlorobiphenyl: Production of Reactive Oxygen by Vertebrate CYP1As
    Jennifer J. Schlezinger, Renee D. White and John J. Stegeman
    Molecular Pharmacology September 1999, 56 (3) 588-597; DOI: https://doi.org/10.1124/mol.56.3.588
  • You have access
    Incorporation of the π Subunit into Functional γ-Aminobutyric AcidA Receptors
    Torben R. Neelands and Robert L. Macdonald
    Molecular Pharmacology September 1999, 56 (3) 598-610; DOI: https://doi.org/10.1124/mol.56.3.598
  • You have access
    A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization
    John P. Roche, Sid Bounds, Sean Brown and Ken Mackie
    Molecular Pharmacology September 1999, 56 (3) 611-618; DOI: https://doi.org/10.1124/mol.56.3.611
  • You have access
    N-methyl-d-aspartate Excitotoxicity: Relationships among Plasma Membrane Potential, Na+/Ca2+ Exchange, Mitochondrial Ca2+ Overload, and Cytoplasmic Concentrations of Ca2+, H+, and K+
    Lech Kiedrowski
    Molecular Pharmacology September 1999, 56 (3) 619-632; DOI: https://doi.org/10.1124/mol.56.3.619
  • You have access
    Molecular Modeling of the Intrastrand Guanine-Guanine DNA Adducts Produced by Cisplatin and Oxaliplatin
    Eric D. Scheeff, James M. Briggs and Stephen B. Howell
    Molecular Pharmacology September 1999, 56 (3) 633-643; DOI: https://doi.org/10.1124/mol.56.3.633
  • You have access
    The N Terminus Domain of Type VI Adenylyl Cyclase Mediates Its Inhibition by Protein Kinase C
    Hsing-Lin Lai, Ting-Hui Lin, Yu-Ya Kao, Wu-Ja Lin, Ming-Jing Hwang and Yijuang Chern
    Molecular Pharmacology September 1999, 56 (3) 644-650; DOI: https://doi.org/10.1124/mol.56.3.644

Accelerated Communications

  • You have access
    Influence of G Protein Type on Agonist Efficacy
    Qing Yang and Stephen M. Lanier
    Molecular Pharmacology September 1999, 56 (3) 651-656; DOI: https://doi.org/10.1124/mol.56.3.651
  • You have access
    Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
    Henry M. Sarau, Robert S. Ames, Jon Chambers, Catherine Ellis, Nabil Elshourbagy, James J. Foley, Dulcie B. Schmidt, Roseanna M. Muccitelli, Owen Jenkins, Paul R. Murdock, Nicole C. Herrity, Wendy Halsey, Ganesh Sathe, Alison I. Muir, Parvathi Nuthulaganti, George M. Dytko, Peter T. Buckley, Shelagh Wilson, Derk J. Bergsma and Douglas W.P. Hay
    Molecular Pharmacology September 1999, 56 (3) 657-663; DOI: https://doi.org/10.1124/mol.56.3.657
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 56 (3)
Molecular Pharmacology
Vol. 56, Issue 3
1 Sep 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Accelerated Communications
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics